A Measure of Health-Related Quality of Life Among Patients with Localized Prostate Cancer: Results from Ongoing Scale Development

The instrument provides a sensitive measure of physiologic differences across the 3 primary treatment groups and indicates that there are few differences across treatment groups on broader aspects of health-related quality of life. Further development of the measure is recommended.